Skip to main content

COVID-19 Vaccine Boosters Aid Outcomes in Patients With Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on July 30, 2025.

via HealthDay

TUESDAY, July 29, 2025 -- COVID-19 vaccination boosters protect people with cancer developing from severe COVID-19, according to a study published online July 17 in JAMA Oncology.

Jacek Skarbinski, M.D., from Oakland Medical Center in California, and colleagues assessed COVID-19 vaccine effectiveness (VE) and the number needed-to-vaccinate (NNV) among people with cancer. The analysis included 72,831 patients with cancer.

The researchers found that during 34,006 person-years of follow-up, the COVID-19 hospitalization rate was 30.5 per 1,000 person-years among patients who received a monovalent booster versus 41.9 per 1,000 person-years among patients who received the primary series alone (adjusted VE of 29.2 percent and NNV to prevent one COVID-19 hospitalization of 166). Significant benefits were also seen to prevent diagnosed COVID-19 (VE, 8.5 percent) and COVID-19-related intensive care unit (ICU) admission (VE, 35.6 percent). Among 88,417 cancer patients, during 81,027 person-years of follow-up in the bivalent period, patients who received this booster (38 percent) had a COVID-19 hospitalization rate of 13.4 per 1,000 person-years versus 21.7 per 1,000 person-years among those who did not receive a bivalent vaccine (adjusted VE of 29.9 percent and NNV to prevent one COVID-19 hospitalization of 451). To prevent COVID-19-related ICU admission, the adjusted VE was 30.1 percent.

"The reduction in hospitalizations was significant, and the number of patients we needed to treat to see a benefit to the boosters is quite low," senior author Jane Figueiredo, Ph.D., from Cedars-Sinai in Los Angeles, said in a statement. "This shows a great benefit to our cancer patients and should encourage patients to discuss vaccination with their health care providers."

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Hepatitis B Virus Immunity Linked to Reduced Risk for Diabetes

THURSDAY, Sept. 11, 2025 -- Hepatitis B virus (HBV) immunity in individuals without HBV infection is associated with a reduced risk for diabetes, according to a study published...

One in 10 Undergoing Early Cancer Surgery Have New Persistent Opioid Use

MONDAY, Sept. 8, 2025 -- More than one in 10 veterans undergoing surgery for early-stage cancer develop new persistent opioid use, according to a study published online Sept. 8 in...

Healthy Plant-Based Diet May Cut Burden of Multimorbidity of Cancer and Cardiometabolic Diseases

MONDAY, Sept. 8, 2025 -- Among middle-aged and older adults, a healthy plant-based diet may reduce the burden of cancer and cardiometabolic diseases, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.